Demyttenaere K, Haddad P. - Compliance with antidepressant therapy and antidepressant discontinuation syndrome. Acta Psychiatr Scand, 2000, 403, 50-56.
Lejoyeux M, Adès J. - Antidepressant discontinuation : a review of the litterature. J Clin Psychiatry, 1997, 58 11-16.
Shelton RC. - The nature of the discontinuation syndrome associated with antidepressant drugs. J Clin Psychiatry, 2006, 67, 3-7.
Young AH, Currie A. - Physicians' knowledge of antidepressant withdrawal effects : a survey. J Clin Psychiatry, 1997, 58, 28-30.
Priest RG, Vize C, Roberts A, et al. - Lay people's attitudes to treatment of depression : results of opinion poll for Defeat Depression Campaign just before its launch. BMJ, 1996, 313, 858-859.
Fava M. - Prospective studies of adverse events related to antidepressant discontinuation. J Clin Psychiatry, 2006, 67, 14-21.
Rosenbaum JF, Fava M, Hoog SL, et al. - Selective serotonin reuptake inhibitor discontinuation syndrome : a randomized clinical trial. Biol Psychiatry, 1998, 44, 77-87.
Michelson D, Fava M, Amsterdam J, et al. - Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry, 2000, 176, 363-368.
Therrien F, Markowitz JS. - Selective serotonin reuptake inhibitors and withdrawal symptoms : a review of the litterature. Hum Psychopharmacol, 1997, 12, 309-323.
Warner CH, Bobo W, Warner C, et al. - Antidepressant discontinuation syndrome. Am Family Physician, 2006, 74, 449-456.
Sanz EJ, de las Cuevas C, Kiuru A, et al. - Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome : a database analysis. Lancet, 2005, 365, 482-487.
Schatzberg AF, Haddad P, Kaplan EM, et al. - Serotonin reuptake inhibitor discontinuation syndrome : a hypothetical definition. J Clin Psychiatry, 1997, 58 (suppl 7), 5-10.
Blier P, Tremblay P. - Physiologic mechanisms underlying the antidepressant discontinuation syndrome. J Clin Psychiatry, 2006, 67, 8-13.
Bogetto F, Bellino S, Revello RB, et al. - Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors : a clinical investigation. CNS Drugs, 2002, 16, 273-283.
Baldwin DS, Cooper JA, Huusom AK, et al. - A double-blind ; randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Int Clin Psychopharmacol, 2006, 21, 159-169.
Judge R, Parry MG, Ouail D, et al. - Discontinuation symptoms : comparison of brief interruption in fluoxetine and paroxetine treatment. Int Clin Psychopharmacol, 2002, 17, 217-225.
Himei A, Okamura T. - Discontinuation syndrome associated with paroxetine in depressed patients : a retrospective analysis of factors in volved in the occurrence of the syndrome. CNS Drugs. 2006, 20, 665-672.
Fava M, Mulroy R, Alpert J, et al. - Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine. Am J Psychiatry, 1997, 154, 1760-1762.
Perahia DG, Kajdasz DK, Desaiah D, et al. - Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder. J Aff Disord, 2005, 89, 207-212.
Pitchot W. - Duloxetine (Cymbalta). Rev Med Liège, 2006, 61, 787-790.
